Explore the latest in ethics, including topics in clinical, research, and publication ethics.
This cross-sectional study explores the vulnerability of older adults to a US government impersonation scam.
This study reviewed public comments for all Medicare National Coverage Determinations between June 2019 and 2022 on select pulmonary and cardiac devices to determine whether financial conflicts of interest were disclosed.
This cross-sectional study evaluates whether research and nonresearch payments from drug manufacturers play a role in opthalmologists’ selection of therapies for age-related macular degeneration.
This essay discusses how the deep work of doctoring leveraged with technology can bring us close to the quadruple aim of better care, better health, lower cost, and fulfilling work.
This cross-sectional study analyzes the role of comorbidities and long-term prognosis in state triage procedures.
This Viewpoint discusses the unfairness of current CAR T-cell therapy allocation practices and offers alternative methods to more fairly allocate therapy.
This cross-sectional study investigates rates of results reporting among oncology clinical trials across trial registries, medical journals, and medical conferences.
This cross-sectional study examines the incidence of hypoxic ischemic encephalopathy in male vs female neonates.
This qualitative study investigates key stakeholders’ perspectives on dual-role consent in clinical oncology trials.
This Viewpoint discusses how regulators across the world should approach the legal and ethical challenges, including privacy, device regulation, competition, intellectual property rights, cybersecurity, and liability, raised by the medical use of large language models.
This Viewpoint discusses the difficult task of creating a stakeholder-driven, evidence-based approach to assessing institutional review board effectiveness beyond regulatory compliance.
This Viewpoint discusses the Medicare Physician Fee Schedule and its flaws, including how they might be remedied by severing CMS dependence on Relative Value Update Committee estimates of time and intensity.
This systematic review assesses US Food and Drug Administration (FDA) 501(k) clearance documents and marketing materials for adherence to guidelines for artificial intelligence– and machine learning–enabled medical devices.
This cohort study of children, adolescents, and young adults treated at pediatric oncology centers in France examines outcomes and safety measures for the use of off-label treatments for cancer.
Customize your JAMA Network experience by selecting one or more topics from the list below.